Back to Search
WILLIAM KWASNY, MD
MD
Anesthesiology Physician
NPI: 1962452532IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
47809(WI)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
MEDICAL COLLEGE OF WISCONSIN
Class of 1999
Research & Publications (20)
[Early experience with the advanced breast biopsy instrumentation system in a multicentre study].
PMID 12373025·Gynakol Geburtshilfliche Rundsch·2002
4-observational
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
PMID 19213681·N Engl J Med·2009
2-rct
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
PMID 18347178·Clin Cancer Res·2008
4-observational
The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).
PMID 18080748·Breast Cancer Res Treat·2008
2-rct
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
PMID 18381948·Clin Cancer Res·2008
3-trial
Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
PMID 18073378·J Natl Cancer Inst·2007
4-observational
Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.
PMID 17513805·J Clin Oncol·2007
4-observational
Phase II trial of pegylated liposomal doxorubicin (Caelyx) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer.
PMID 17453371·Acta Oncol·2007
3-trial
Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
PMID 17363187·Int J Radiat Oncol Biol Phys·2007
4-observational
Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
PMID 12637461·J Clin Oncol·2003
3-trial
Impact of pretreatment thrombocytosis on survival in primary breast cancer.
PMID 12783124·Thromb Haemost·2003
8-other
Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma.
PMID 12698181·Br J Cancer·2003
3-trial
Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group.
PMID 12677153·Ann Surg·2003
4-observational
Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial.
PMID 12488300·Ann Oncol·2003
3-trial
Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor.
PMID 12006518·Clin Cancer Res·2002
3-trial
Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5.
PMID 12488405·J Clin Oncol·2002
3-trial
Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
PMID 12060624·Clin Cancer Res·2002
4-observational
Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor.
PMID 11157011·J Clin Oncol·2001
3-trial
Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trial.
PMID 11283925·Cancer·2001
3-trial
Prognostic relevance of three histological grading methods in breast cancer.
PMID 11713599·Int J Oncol·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1506 S ONEIDA ST
APPLETON, WI 54915 - Phone
- (920) 738-2000
Quick Facts
- NPI
- 1962452532
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile